GlaxoSmithKline dividend 'still unsustainable', says UBS
27th Oct 2014 10:32
UBS has cut its target price for GlaxoSmithKline after trimming its estimates for the pharmaceutical company, and said that its dividend "still looks unsustainable". The bank has reduced its target for the shares from 1,380p to 1,250p and kept a 'sell' rating. Following Glaxo's recent third-quarter
Read moreFTSE 100 movers: Tesco leads downside after profits slide
23rd Oct 2014 14:46
Tesco led the downside after its first-half trading profits fell 39.4% at constant exchange rates to £937m. Tesco's chairman Sir Richard Broadbent announced his own succession process had begun, as the company's UK like-for-like sales fell 4.6%. Although its pension deficit surged from £2.6bn to £3.
Read moreThursday broker round-up UPDATE
23rd Oct 2014 08:33
Abcam: FinnCap moves target price from 390p to 400p keeping a hold recommendation. Anglo American: Investec places its target price (prev.: 1603p) under review keeping its buy recommendation. Arbuthnot: Numis raises target price from 1150p to 1300p upgrading from hold to add. British American Taba
Read moreLondon close: Markets up on positive company news
22nd Oct 2014 17:04
The London market closed in positive territory for the second time this week as traders weary of negative economic news took heart from upbeat corporate results. The FTSE 100 Index ended the session 27.4 points ahead at 6399.73 as drug group GlaxoSmithKline pleased investors with news of higher earn
Read moreFTSE 100 movers: GlaxoSmithKline leads risers after pleasing with Q3 results
22nd Oct 2014 16:05
Drug giant Glaxosmithkline (GSK) rose after the pharmaceutical giant said core operating profit fell by just 6% to £1.89bn, compared with the £1.71bn forecast. Figures out from AA Insurance lifted shares in car insurers on Wednesday, with Direct Line and Admiral both parking themselves in the top 10
Read moreBroker tips: GSK, BHP Billiton, International Personal Finance, Supergroup
22nd Oct 2014 13:19
Hargreaves Lansdown says the City may take a more charitable view of Glaxosmithkline shares after the drug group announced higher third-quarter earnings per share and a streamlining of its business. The broker said analysts may need to "positively re-evaluate" the market consensus on the shares as a
Read moreMarket may need to revisit Glaxo stance, says Hargreaves Lansdown
22nd Oct 2014 12:49
Hargreaves Lansdown says the City may take a more charitable view of Glaxosmithkline shares after the drug group announced higher third quarter earnings per share and a streamlining of its business. The broker said analysts may need to "positively re-evaluate" the market consensus on the shares as a
Read moreGlaxoSmithKline Q3 profits fall but EPS up - UPDATE
22nd Oct 2014 11:56
Drug giant Glaxosmithkline (GSK) announced lower third quarter sales and profits as weak trading in the US and Europe overshadowed a strong performance in emerging markets, although earnings per share rose excluding divestments. GSK said third quarter turnover fell 3% at constant exchange rates and
Read moreLondon midday: UK stocks flat amid central-bank speculation
22nd Oct 2014 11:42
UK stocks were broadly flat on Wednesday morning after jumping to a one-week high the previous session, as investors reacted to ongoing central-bank speculation and digested mixed corporate earnings. The FTSE 100 was down 0.05% at 6,369 by midday, with results from the likes of British American Toba
Read moreWednesday broker round-up UPDATE
22nd Oct 2014 09:54
Amino Technologies: N+1 Singer moves target price from 93p to 107p upgrading to buy. Anglo American: Liberum Capital reduces target price from 1300p to 1200p retaining its sell recommendation. ARM Holdings: UBS moves target price from 970p to 980p upgrading from neutral to buy. Deutsche Bank cuts t
Read moreWednesday preview: Glaxo, MPC minutes, US CPI all due out
21st Oct 2014 15:11
Glaxosmithklline will be among the most high-profile companies to release results on Wendesday as the pharmaceutical giant reports its third-quarter figures. The drugmaker is expected to deliver sales of £5.74bn in the three months to 30 September, down from £6.51bn in the third quarter of 2013. Th
Read moreFTSE 100 movers: Travel stocks fly higher
21st Oct 2014 14:51
Travel stocks were once again in positive territory as the sector recovered from a recent poor performance amid mounting concerns about the Ebola crisis. A report from Reuters claiming the European Central Bank is considering the possibility of buying corporate bonds on the secondary market, potenti
Read moreMonday broker round-up UPDATE
13th Oct 2014 09:32
Amino Technologies: Northland Capital upgrades to buy with a target price of 100p. Anglo American: Canaccord Genuity initiates with a target price of 1720p and a buy recommendation. Credit Suisse upgrades to outperform with a target price of 1800p. Associated British Foods: Societe Generale upgrade
Read moreLondon midday: Mining gains offset by falls from airline, healthcare stocks
7th Oct 2014 11:36
Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals. The FTSE 100 was trading 0.6% lower at 6,522 by around midday. Nervousness ahead of the start of third-quarter earnings season in the States was also ca
Read moreTuesday broker round-up UPDATE
7th Oct 2014 09:45
African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc
Read more